Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids

Abstract Reduced taste sensitivity to 6-n-propylthiouracil (PROP), a genetic trait regarded as a general index for oral chemosensory perception, has been associated with a calorie-rich food preference and lower circulating endocannabinoid levels in participants with normal weight (NW), which suggest...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gianfranca Carta, Melania Melis, Stefano Pintus, Paolo Pintus, Carla A. Piras, Laura Muredda, Daniela Demurtas, Vincenzo Di Marzo, Sebastiano Banni, Iole Tomassini Barbarossa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/044e5aee3e6c42f39187e7b686e46d24
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:044e5aee3e6c42f39187e7b686e46d24
record_format dspace
spelling oai:doaj.org-article:044e5aee3e6c42f39187e7b686e46d242021-12-02T11:52:59ZParticipants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids10.1038/s41598-017-01562-12045-2322https://doaj.org/article/044e5aee3e6c42f39187e7b686e46d242017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01562-1https://doaj.org/toc/2045-2322Abstract Reduced taste sensitivity to 6-n-propylthiouracil (PROP), a genetic trait regarded as a general index for oral chemosensory perception, has been associated with a calorie-rich food preference and lower circulating endocannabinoid levels in participants with normal weight (NW), which suggests an adaptive mechanism to maintain a lean phenotype. In this study, we assessed whether participants with obesity (OB) show different patterns of plasma endocannabinoids and lipid metabolism biomarkers from those of NW, with further categorization based on their PROP sensitivity. NW and OB were classified by their PROP taster status as non-tasters (NT), medium-tasters (MT) and supertasters (ST). The blood samples were analysed for plasma endocannabinoids, nonesterified fatty acids (NEFA) and retinol, which have been associated to metabolic syndrome. In OB, we found a higher BMI and lower circulating endocannabinoids in ST vs. OB NT. However, OB ST showed lower circulating NEFA and retinol levels, which suggested a more favourable lipid metabolism and body fat distribution than those of OB NT. We confirmed lower plasma endocannabinoid levels in NW NT than in NW ST. These data suggest that PROP taste sensitivity determines metabolic changes and ultimately body mass composition differently in OB and NW.Gianfranca CartaMelania MelisStefano PintusPaolo PintusCarla A. PirasLaura MureddaDaniela DemurtasVincenzo Di MarzoSebastiano BanniIole Tomassini BarbarossaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gianfranca Carta
Melania Melis
Stefano Pintus
Paolo Pintus
Carla A. Piras
Laura Muredda
Daniela Demurtas
Vincenzo Di Marzo
Sebastiano Banni
Iole Tomassini Barbarossa
Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
description Abstract Reduced taste sensitivity to 6-n-propylthiouracil (PROP), a genetic trait regarded as a general index for oral chemosensory perception, has been associated with a calorie-rich food preference and lower circulating endocannabinoid levels in participants with normal weight (NW), which suggests an adaptive mechanism to maintain a lean phenotype. In this study, we assessed whether participants with obesity (OB) show different patterns of plasma endocannabinoids and lipid metabolism biomarkers from those of NW, with further categorization based on their PROP sensitivity. NW and OB were classified by their PROP taster status as non-tasters (NT), medium-tasters (MT) and supertasters (ST). The blood samples were analysed for plasma endocannabinoids, nonesterified fatty acids (NEFA) and retinol, which have been associated to metabolic syndrome. In OB, we found a higher BMI and lower circulating endocannabinoids in ST vs. OB NT. However, OB ST showed lower circulating NEFA and retinol levels, which suggested a more favourable lipid metabolism and body fat distribution than those of OB NT. We confirmed lower plasma endocannabinoid levels in NW NT than in NW ST. These data suggest that PROP taste sensitivity determines metabolic changes and ultimately body mass composition differently in OB and NW.
format article
author Gianfranca Carta
Melania Melis
Stefano Pintus
Paolo Pintus
Carla A. Piras
Laura Muredda
Daniela Demurtas
Vincenzo Di Marzo
Sebastiano Banni
Iole Tomassini Barbarossa
author_facet Gianfranca Carta
Melania Melis
Stefano Pintus
Paolo Pintus
Carla A. Piras
Laura Muredda
Daniela Demurtas
Vincenzo Di Marzo
Sebastiano Banni
Iole Tomassini Barbarossa
author_sort Gianfranca Carta
title Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
title_short Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
title_full Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
title_fullStr Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
title_full_unstemmed Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids
title_sort participants with normal weight or with obesity show different relationships of 6-n-propylthiouracil (prop) taster status with bmi and plasma endocannabinoids
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/044e5aee3e6c42f39187e7b686e46d24
work_keys_str_mv AT gianfrancacarta participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT melaniamelis participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT stefanopintus participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT paolopintus participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT carlaapiras participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT lauramuredda participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT danielademurtas participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT vincenzodimarzo participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT sebastianobanni participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
AT ioletomassinibarbarossa participantswithnormalweightorwithobesityshowdifferentrelationshipsof6npropylthiouracilproptasterstatuswithbmiandplasmaendocannabinoids
_version_ 1718394906318209024